Barclays Maintains Underweight on XPLR Infr, Lowers Price Target to $10
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $11 to $10.
Barclays analyst Betty Jing maintains XPLR Infr (NYSE:XIFR) with a Underweight and lowers the price target from $11 to $10.